drugset / Trial / NCT07633691
A Study to Exploratively Evaluate the Safety, Tolerability and Pharmacokinetics of DA-5223 Compared With DA-5223-R in Healthy Adult Subjects
RandomizedCrossoverOpen-labelTreatment
Summary
This study will exploratively evaluate the safety, tolerability and pharmacokinetics of DA-5223 compared with DA-5223-R in healthy adult subjects
Timeline
- Start
- 2026-06-15
- Primary completion
- 2026-06-23
- Completion
- 2026-07-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | DA-5223-F | Unknown | — | — |
| Subject | DA-5223-M | Unknown | — | — |
| Subject | DA-5223-R | Unknown | — | — |
Indications
No indication recorded.